loading...| Preferred Name |
Intravenous thrombolysis |
|
| Synonyms |
|
|
| ID |
http://www.semanticweb.org/ontologies/STO.owl#OWLClass_f81a7c2f_5c16_4834_aafa_262dc08653d6 |
|
| isDefinedBy |
Intravenous (IV) thrombolysis with tissue plasminogen activator (tPA, alteplase) is the standard of care in the treatment of acute ischemic stroke in current clinical practice and the extension of the time window up to 4.5 hours after symptoms onset has been already approved by the European Medicines Agency (EMEA) and US Food and Drug Administration (FDA) agency and included in European and American guidelines recommendations. |
|
| label |
Intravenous thrombolysis |
|
| prefixIRI |
OWLClass_f81a7c2f_5c16_4834_aafa_262dc08653d6 |
|
| prefLabel |
Intravenous thrombolysis |
|
| references |
Dorado, L., Millán, M., & Dávalos, A. (2014). Reperfusion Therapies for Acute Ischemic Stroke: An Update. Current Cardiology Reviews, 10(4), 327–335. http://doi.org/10.2174/1573403X10666140320144637 |
|
| synonyms |
IV thrombolysis |
|
| subClassOf |
http://www.semanticweb.org/ontologies/STO.owl#OWLClass_0015376d_c3a4_4a8c_9943_deeefca48876 |